Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Directorate Changes

15 Sep 2014 07:00

RNS Number : 6056R
Eland Oil & Gas PLC
15 September 2014
 



 

15 September 2014

 

Eland Oil & Gas PLC

("Eland" or the "Company")

 

Directorate Changes

 

Eland Oil & Gas PLC (AIM: ELA), an oil & gas development and exploration company operating in West Africa with an initial focus on Nigeria, today announces the resignation of Andrew Bartlett from his position as a Non-Executive Director of the Company. Eland would like to thank Andrew for all his work and contribution to the Company since 2012. We wish him well in his future endeavours.

 

Eland is pleased to announce the appointment of Dr Richard Norris as Non-Executive Director of the Company to replace Andrew Bartlett. Richard joins the Board today and will represent Helios Natural Resources, a significant shareholder in Eland.

 

Dr Richard Norris has over 25 years' oil and gas experience and is currently Upstream Adviser to Helios Investment Partners. In his early career, Richard held the position of Reservoir Engineer at Elf Aquitaine, subsequently Total, covering upstream operations, reserves, new ventures and economic strategy over a ten year period in France and Angola. Later he established the Technical Director role at BNP Paribas in its European oil and gas structured finance group. More recently he was General Operations Manager for Geopetrol and subsequently in 2010-2011 Richard was CEO and President of the TSX listed Candax Energy.

 

Richard holds a PhD in Petroleum Engineering and an MSc in Petroleum Geology from Imperial College London as well as a BSc in Geology.

 

Dr Richard Norris (age 48) directorships in the last five years are as follows:

 

Current

Wannasurf.com Limited

Pandreco Limited

 

Last 5 years

Candax Energy Limited

 

Richard Norris shareholdings in the Company:

Under a success fee arrangement with Helios, Richard Norris is a Limited Partner in HNR Co-Investment Partners LLP ("HNR Co-Investment"), with Helios as the General Partner, whereby HNR Co-Investment indirectly holds on Richard Norris's behalf, 79,845 ordinary shares in Eland (representing 0.06% of the current issued share capital of the Company) through its investment in Helios Natural Resources Ltd whose only asset is shares in Eland. Any monetisation of the indirect stake is at the sole discretion of the General Partner.

Helios hold, through Helios Natural Resources Limited, 39,600,000 ordinary shares in the Company, including those held on behalf of Dr Norris as described above, representing 28.03% of the current issued share capital of the Company. Helios Natural Resources also hold an additional 10,000,000 Non-Voting Shares.

 

There is no further information to be disclosed in relation to schedule 2 paragraph (g) of the AIM rules.

 

 

For further information:

Eland Oil & Gas PLC

+44 (0) 207 016 3180

George Maxwell, CEO

 

Louis Castro, CFO

 

Edward Cozens, IR

 

 

 

Canaccord Genuity Limited

+44 (0) 207 523 8000

Henry Fitzgerald-O'Connor

 

Peter Stewart

 

 

FirstEnergy Capital LLP

+44 (0) 207 448 0200

Majid Shafiq

 

Khalid Ahmed

 

 

Citigate Dewe Rogerson

+44 (0) 207 638 9571

Martin Jackson

Shabnam Bashir

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUCGBUPCGRC
Date   Source Headline
17th Jul 20095:57 pmBUSStudies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
16th Jul 20092:18 pmRNSResults of Annual General Meeting
13th Jul 200911:30 amBUSElan and Transition Therapeutics Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid
10th Jul 20094:59 pmRNSCancellation of UK Listing
8th Jul 20097:00 amBUSElan Announces Webcast of Second Quarter 2009 Financial Results
3rd Jul 200910:57 amRNSBlock Listing Six Monthly Return
2nd Jul 200912:57 pmRNSHolding in Company
2nd Jul 200912:41 pmPRNJohnson & Johnson, Elan Announce Definitive Agreement
1st Jun 20097:00 amBUSSubset Data from Two Randomized Phase 3 Trials Show TYSABRI® Significantly Improves Health-Related Quality of Life for Crohn's Disease Patients with Prior Exposure or Inadequate Response to Anti-TNF? Therapy
29th May 20094:36 pmRNSPrice Monitoring Extension
29th May 20092:00 pmBUSRenee P. Tannenbaum, Pharm.D. Joins Elan as Executive Vice President and Chief Commercial Officer
29th May 200911:54 amBUSTotal Voting Rights
30th Apr 200912:16 pmBUSTotal Voting Rights
27th Apr 20093:35 pmRNSAnnual Report
14th Apr 20095:09 pmRNSHolding(s) in Company
27th Feb 20092:44 pmBUSTotal Voting Rights
25th Feb 200912:23 pmBUSDirector/PDMR Shareholding
12th Feb 20096:00 pmBUSDirector/PDMR Shareholding
12th Feb 20096:00 pmBUSDirector/PDMR Shareholding
9th Feb 20097:00 amBUSMS Patients Treated with TYSABRI® Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology
4th Feb 20092:32 pmRNSHolding(s) in Company
3rd Feb 20093:57 pmRNSHolding(s) in Company
30th Jan 20094:33 pmRNSHolding(s) in Company
28th Jan 20094:24 pmRNSHolding(s) in Company
13th Jan 20097:00 amBUSElan Clarifies Duration of Bapineuzumab Phase 3 Trials
12th Jan 20095:21 pmRNSHolding(s) in Company
12th Jan 20097:00 amBUSTysabri Update
2nd Jan 200912:21 pmRNSTotal Voting Rights
18th Dec 20084:24 pmRNSBlock Listing Six Monthly Return
16th Dec 200811:00 amBUSDirector Declaration
16th Dec 20087:00 amBUSElan to Present at the 27th Annual JP Morgan Healthcare Conference
15th Dec 20083:02 pmBUSTysabri Update
12th Dec 20087:00 amBUSElan Announces Resource Realignment
28th Nov 200810:47 amBUSTotal Voting Rights
25th Nov 20087:00 amBUSMary Stutts to Join Elan as Senior Vice President and Head of Corporate Relations
20th Nov 20087:00 amBUSCarlos V. Paya, MD, PhD, to Join Elan as Company President
3rd Nov 20085:12 pmRNSDirector/PDMR Shareholding
31st Oct 20084:11 pmRNSHolding in Company
31st Oct 200812:01 pmRNSTotal Voting Rights
30th Oct 20084:13 pmRNSTysabri Update
3rd Oct 20085:56 pmRNSHolding in Company
30th Sep 20084:11 pmRNSTotal Voting Rights
22nd Sep 200811:26 amRNSHolding In Company
22nd Sep 20087:00 amRNSTysabri Demonstrates Sustained Improvement
11th Sep 20087:39 amRNSDirector /PDMR Shareholding
1st Sep 20085:02 pmRNSHolding(s) in Company
29th Aug 200810:54 amRNSTotal Voting Rights
28th Aug 20087:00 amRNSInterim Results
14th Aug 20084:12 pmRNSHolding in Company
13th Aug 20085:22 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.